Some Morphology Frontiers of Dysplasia in the Tubular Gastrointestinal Tract: The Rodger C. Haggitt Memorial Lecture.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
01 01 2022
01 01 2022
Historique:
pubmed:
8
12
2020
medline:
15
2
2022
entrez:
7
12
2020
Statut:
ppublish
Résumé
This review, based on the content of the 2020 US Gastrointestinal Pathology Society's Rodger Haggitt Lecture, concerns an array of tubular gastrointestinal tract dysplastic or possible "predysplastic lesions" with an almost purely morphologic focus based on our collaborative efforts over the past few years. These processes include esophageal epidermoid metaplasia, Barrett esophagus-associated dysplasia, polypoid gastric dysplastic lesions, small intestinal dysplasia, and the ability of metastases to mimic it, the controversial "serrated epithelial change" encountered in the setting of long-standing ulcerative and Crohn colitis, and recently described anal columnar human papilloma virus-associated neoplasms.
Identifiants
pubmed: 33284191
pii: 00000478-202201000-00001
doi: 10.1097/PAS.0000000000001637
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Lecture
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e14Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Références
World Health Organization. Digestive system tumours. In: WHO Classification of Tumours Editorial Board. Lyon, France: International Agency for Research on Cancer; 2019.
Singhi AD, Arnold CA, Crowder CD, et al. Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients. Mod Pathol. 2014;27:38–43.
Singhi AD, Arnold CA, Lam-Himlin DM, et al. Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia. Mod Pathol. 2017;30:1613–1621.
Taggart MW, Rashid A, Ross WA, et al. Oesophageal hyperkeratosis: clinicopathological associations. Histopathology. 2013;63:463–473.
Trump BF, McDowell EM, Glavin F, et al. The respiratory epithelium. III. Histogenesis of epidermoid metaplasia and carcinoma in situ in the human. J Natl Cancer Inst. 1978;61:563–575.
American Gastroenterological Association, Spechler SJ, Sharma P, et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.
Shaheen NJ, Falk GW, Iyer PG, et al. American College of Gastroenterology. ACG Clinical Guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:30–50; quiz 51.
Shaheen NJ, Falk GW, Iyer PG, et al. Corrigendum: ACG Clinical Guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111:1077.
Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.
Salimian KJ, Waters KM, Eze O, et al. Definition of Barrett esophagus in the United States: support for retention of a requirement for goblet cells. Am J Surg Pathol. 2018;42:264–268.
Chandrasoma P, Wijetunge S, DeMeester S, et al. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg Pathol. 2012;36:1–7.
Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368–378.
Waters KM, Salimian KJ, Voltaggio L, et al. Refined criteria for separating low-grade dysplasia and nondysplastic barrett esophagus reduce equivocal diagnoses and improve prediction of patient outcome: a 10-year review. Am J Surg Pathol. 2018;42:1723–1729.
Abraham SC, Montgomery EA, Singh VK, et al. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol. 2002;26:1276–1285.
Bosman F, Carneiro F, Hruban R, Theise N, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC; 2010.
Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch. 2012;460:19–46.
Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51:365–388.
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489.e26–501.e26.
Chen ZM, Scudiere JR, Abraham SC, et al. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol. 2009;33:186–193.
Vieth M, Kushima R, Borchard F, et al. Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch. 2003;442:317–321.
Aida J, Vieth M, Shepherd NA, et al. Is carcinoma in columnar-lined esophagus always located adjacent to intestinal metaplasia?: A histopathologic assessment. Am J Surg Pathol. 2015;39:188–196.
Hackeng WM, Montgomery EA, Giardiello FM, et al. Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis. Histopathology. 2017;70:549–557.
Wood LD, Salaria SN, Cruise MW, et al. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol. 2014;38:389–393.
Gupta S, Li D, El Serag HB, et al. AGA Clinical Practice Guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158:693–702.
Park JY, Cornish TC, Lam-Himlin D, et al. Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting. Am J Surg Pathol. 2010;34:1591–1598.
Pittman ME, Voltaggio L, Bhaijee F, et al. Autoimmune metaplastic atrophic gastritis: recognizing precursor lesions for appropriate patient evaluation. Am J Surg Pathol. 2015;39:1611–1620.
Abraham SC, Park SJ, Lee JH, et al. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol. 2003;16:786–795.
Cao H, Wang B, Zhang Z, et al. Distribution trends of gastric polyps: an endoscopy database analysis of 24,121 Northern Chinese patients. J Gastroenterol Hepatol. 2012;27:1175–1180.
Carmack SW, Genta RM, Schuler CM, et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.
Brosens LA, Giardiello FM, Offerhaus GJ, et al. Syndromic gastric polyps: at the crossroads of genetic and environmental cancer predisposition. Adv Exp Med Biol. 2016;908:347–369.
Nakamura S, Matsumoto T, Kobori Y, et al. Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut. 2002;51:485–489.
Park DY, Srivastava A, Kim GH, et al. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. Am J Surg Pathol. 2008;32:524–533.
Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378:1085–1095.
Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–397.
Bunn HF. Vitamin B12 and pernicious anemia—the dawn of molecular medicine. N Engl J Med. 2014;370:773–776.
Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368:149–160.
Choi WT, Brown I, Ushiku T, et al. Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases. Histopathology. 2018;72:1007–1014.
Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity! J Clin Pathol. 2014;67:883–890.
Li J, Woods SL, Healey S, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Hum Genet. 2016;98:830–842.
Wood LD, Noe M, Hackeng W, et al. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch. 2017;470:391–400.
Ma C, Giardiello FM, Montgomery EA. Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation. Am J Surg Pathol. 2014;38:1618–1626.
Hashimoto T, Ogawa R, Matsubara A, et al. Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features. Histopathology. 2015;67:689–698.
Matsubara A, Sekine S, Kushima R, et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol. 2013;229:579–587.
Vieth M, Kushima R, Mukaisho K, et al. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch. 2010;457:529–536.
Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609–619.
Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol. 2012;36:1030–1035.
Ushiku T, Kunita A, Kuroda R, et al. Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology. Mod Pathol. 2020;33:206–216.
Hidaka Y, Mitomi H, Saito T, et al. Alteration in the Wnt/beta-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol. 2013;44:2438–2448.
Nomura R, Saito T, Mitomi H, et al. GNAS mutation as an alternative mechanism of activation of the Wnt/beta-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. Hum Pathol. 2014;45:2488–2496.
Waters KM, Salimian KJ, Assarzadegan N, et al. Cell polarity (the “Four Lines”) distinguishes gastric dysplasia from epithelial changes in reactive gastropathy. Histopathology. 2020. [In press].
Estrella JS, Wu TT, Rashid A, et al. Mucosal colonization by metastatic carcinoma in the gastrointestinal tract: a potential mimic of primary neoplasia. Am J Surg Pathol. 2011;35:563–572.
Rosty C, Pai RK, Graham RP. Clinical and histological features of secondary carcinomas in gastrointestinal tract biopsies. Histopathology. 2020;77:622–630.
Bellizzi AM, Montgomery EA, Hornick JL. American Registry of Pathology Expert Opinions: evaluation of poorly differentiated malignant neoplasms on limited samples—gastrointestinal mucosal biopsies. Ann Diagn Pathol. 2020;44:151419.
Wilentz RE, Su GH, Dai JL, et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am J Pathol. 2000;156:37–43.
Odze RD, Farraye FA, Hecht JL, et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:534–541.
Quinn AM, Farraye FA, Naini BV, et al. Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn’s disease. Inflamm Bowel Dis. 2013;19:1186–1193.
Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931–968.
Choi WT, Yozu M, Miller GC, et al. Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study. Mod Pathol. 2020;33:933–943.
Kilgore SP, Sigel JE, Goldblum JR. Hyperplastic-like mucosal change in Crohn’s disease: an unusual form of dysplasia? Mod Pathol. 2000;13:797–801.
Parian A, Koh J, Limketkai BN, et al. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016;84:87.e1–95.e1.
Galandiuk S, Rodriguez-Justo M, Jeffery R, et al. Field cancerization in the intestinal epithelium of patients with Crohn’s ileocolitis. Gastroenterology. 2012;142:855.e8–864.e8.
Ko HM, Harpaz N, McBride RB, et al. Serrated colorectal polyps in inflammatory bowel disease. Mod Pathol. 2015;28:1584–1593.
Polydorides AD, Harpaz N. Serrated lesions in inflammatory bowel disease. Gastrointest Endosc. 2017;85:461.
Darragh TM, Colgan TJ, Cox JT, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205–242.
Krishnamurti U, Mohammad M, Monsrud A, et al. Diagnosing anal squamous intraepithelial lesions with and without p16: an interobserver variability study. J Low Genit Tract Dis. 2020;24:69–74.
Arnold CA, Limketkai BN, Illei PB, et al. Syphilitic and lymphogranuloma venereum (LGV) proctocolitis: clues to a frequently missed diagnosis. Am J Surg Pathol. 2013;37:38–46.
Voltaggio L, Montgomery EA, Ali MA, et al. Sex, lies, and gastrointestinal tract biopsies: a review of selected sexually transmitted proctocolitides. Adv Anat Pathol. 2014;21:83–93.
Waters KM, Cox BK, Wong MT, et al. Lymphogranuloma venereum (LGV) of the anorectum: evaluation of clinicopathologic associations and the utility of a novel RNA in situ hybridization stain. Histopathology. 2020. [In press].
Goddard SL, Poynten IM, Petoumenous K, et al. Prevalence, incidence and predictors of anal Chlamydia trachomatis , anal Neisseria gonorrhoeae and syphilis among older gay and bisexual men in the longitudinal Study for the Prevention of Anal Cancer (SPANC). Sex Transm Infect. 2019;95:477–483.
Voltaggio L, McCluggage WG, Iding JS, et al. A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas. Mod Pathol. 2020;33:944–952.